Keith Meadors - Precipio VP Division

PRPO Stock  USD 6.00  0.14  2.28%   

Insider

Keith Meadors is VP Division of Precipio
Address 4 Science Park, New Haven, CT, United States, 06511
Phone203 787 7888
Webhttps://www.precipiodx.com

Precipio Management Efficiency

The company has return on total asset (ROA) of (0.1898) % which means that it has lost $0.1898 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2922) %, meaning that it created substantial loss on money invested by shareholders. Precipio's management efficiency ratios could be used to measure how well Precipio manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of November 2024, Return On Tangible Assets is likely to drop to -1.16. In addition to that, Return On Capital Employed is likely to drop to -0.53. At this time, Precipio's Total Assets are very stable compared to the past year. As of the 22nd of November 2024, Other Current Assets is likely to grow to about 653.3 K, while Non Current Assets Total are likely to drop about 11.8 M.
Precipio currently holds 1.12 M in liabilities with Debt to Equity (D/E) ratio of 0.06, which may suggest the company is not taking enough advantage from borrowing. Precipio has a current ratio of 2.15, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Precipio's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Maria JDbioAffinity Technologies,
68
Matt StaufferBiodesix
N/A
Ryan SiurekBiodesix
52
Paul KearneySera Prognostics
56
Jeffrey BojarBiodesix
N/A
Abraham EsqCaredx Inc
51
Olesya CPANatera Inc
N/A
John AbbottCastle Biosciences
N/A
Bob HalbertStar Equity Holdings
N/A
Matthew MolchanStar Equity Holdings
57
Werner BaumgartnerPsychemedics
N/A
Mark HazeltineExagen Inc
50
Richard ColemanStar Equity Holdings
68
Paul BeresfordBiodesix
N/A
Wim CriekingeMDxHealth SA ADR
52
Robert HarrisonSera Prognostics
58
Heinrich RderBiodesix
N/A
John BonifaceSera Prognostics
62
Bobbi CoffinBiodesix
N/A
Carl BScGenetic Technologies
69
LLM LLMNatera Inc
55
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. Precipio operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 55 people. Precipio (PRPO) is traded on NASDAQ Exchange in USA. It is located in 4 Science Park, New Haven, CT, United States, 06511 and employs 51 people. Precipio is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

Precipio Leadership Team

Elected by the shareholders, the Precipio's board of directors comprises two types of representatives: Precipio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Precipio. The board's role is to monitor Precipio's management team and ensure that shareholders' interests are well served. Precipio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Precipio's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ahmed Sabet, Chief Officer
Miri ChikoRadomski, Chief Officer
Keith Meadors, VP Division
Matthew Gage, Interim Officer
Ilan Danieli, President CEO, Director
Ayman MD, Chief Officer

Precipio Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Precipio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Precipio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Precipio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precipio will appreciate offsetting losses from the drop in the long position's value.

Moving against Precipio Stock

  0.67LH LaboratoryPairCorr
  0.57GH Guardant HealthPairCorr
  0.53VEEV Veeva Systems ClassPairCorr
  0.53VREX Varex Imaging CorpPairCorr
  0.51VVOS Vivos TherapeuticsPairCorr
The ability to find closely correlated positions to Precipio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Precipio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Precipio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Precipio to buy it.
The correlation of Precipio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Precipio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Precipio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Precipio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Precipio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Precipio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Precipio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Precipio Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precipio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
To learn how to invest in Precipio Stock, please use our How to Invest in Precipio guide.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precipio. If investors know Precipio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precipio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.81)
Revenue Per Share
11.73
Quarterly Revenue Growth
0.257
Return On Assets
(0.19)
Return On Equity
(0.29)
The market value of Precipio is measured differently than its book value, which is the value of Precipio that is recorded on the company's balance sheet. Investors also form their own opinion of Precipio's value that differs from its market value or its book value, called intrinsic value, which is Precipio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precipio's market value can be influenced by many factors that don't directly affect Precipio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precipio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Precipio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precipio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.